Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
119.24
+2.42 (2.07%)
Nov 20, 2024, 4:00 PM EST - Market closed

Jazz Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
3,9933,8343,6593,0942,3642,162
Upgrade
Revenue Growth (YoY)
5.23%4.78%18.26%30.91%9.34%14.32%
Upgrade
Cost of Revenue
294.67284.13267.13217.68148.92127.93
Upgrade
Gross Profit
3,6983,5503,3922,8772,2152,034
Upgrade
Selling, General & Admin
1,3761,3071,3991,399879.85761.87
Upgrade
Research & Development
834.34823.89555.41476.33309.76274.8
Upgrade
Operating Expenses
2,8302,7392,5532,4011,4491,391
Upgrade
Operating Income
867.63810.73839.14475.26765.46642.35
Upgrade
Interest Expense
-352.47-354.54-299.74-280.57-110.81-72.26
Upgrade
Interest & Investment Income
95.365.111.51.811.1-
Upgrade
Earnings From Equity Investments
-2.11-3.01-9.92-0.71-2.96-4.09
Upgrade
Currency Exchange Gain (Loss)
7.478.79-19.01-4.35-3.27-5.81
Upgrade
EBT Excluding Unusual Items
615.83527.07521.97191.43659.52560.19
Upgrade
Merger & Restructuring Charges
-129.57-151.45-326.88-304.99--
Upgrade
Asset Writedown
-61.7-61.7-133.65--136.14-
Upgrade
Pretax Income
396.55294.92-382.71-113.55272.13450.21
Upgrade
Income Tax Expense
-66.61-119.91-158.65216.1233.52-73.15
Upgrade
Earnings From Continuing Operations
463.16414.83-224.06-329.67238.62523.37
Upgrade
Net Income
463.16414.83-224.06-329.67238.62523.37
Upgrade
Net Income to Common
463.16414.83-224.06-329.67238.62523.37
Upgrade
Net Income Growth
479.28%----54.41%17.06%
Upgrade
Shares Outstanding (Basic)
626363605657
Upgrade
Shares Outstanding (Diluted)
687263605758
Upgrade
Shares Change (YoY)
-2.29%15.23%4.77%5.62%-1.79%-6.00%
Upgrade
EPS (Basic)
7.436.55-3.58-5.524.289.22
Upgrade
EPS (Diluted)
7.046.10-3.58-5.524.229.09
Upgrade
EPS Growth
458.10%----53.58%24.52%
Upgrade
Free Cash Flow
1,1301,0681,243750.87884.64736.27
Upgrade
Free Cash Flow Per Share
16.6014.8219.8712.5815.6512.79
Upgrade
Gross Margin
92.62%92.59%92.70%92.97%93.70%94.08%
Upgrade
Operating Margin
21.73%21.14%22.93%15.36%32.39%29.71%
Upgrade
Profit Margin
11.60%10.82%-6.12%-10.65%10.10%24.21%
Upgrade
Free Cash Flow Margin
28.30%27.86%33.97%24.27%37.43%34.06%
Upgrade
EBITDA
1,5181,4491,4691,0281,0441,013
Upgrade
EBITDA Margin
38.03%37.80%40.13%33.21%44.16%46.84%
Upgrade
D&A For EBITDA
650.85638.7629.47552.48278.25370.16
Upgrade
EBIT
867.63810.73839.14475.26765.46642.35
Upgrade
EBIT Margin
21.73%21.14%22.93%15.36%32.39%29.71%
Upgrade
Effective Tax Rate
----12.32%-
Upgrade
Revenue as Reported
3,9933,8343,6593,0942,3642,162
Upgrade
Advertising Expenses
-92.2108.8161.599.665.4
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.